Keros Therapeutics Inc (KROS)
11.19 -0.25 (-2.19%) 11:14 ET [NASDAQ]
11.23 x 99 11.30 x 50
Realtime by (Cboe BZX)
11.23 x 99 11.30 x 50
Realtime - - (-) -
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select FieldsSymbol | KROS | SAGE | STOK | ||
Company | Keros Therapeutics Inc | Sage Therapeutic Com | Stoke Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 11.35 | 7.94 | 8.21 | ||
High | 11.51 | 8.08 | 8.35 | ||
Low | 11.20 | 7.94 | 7.90 | ||
Last | 11.19 | 8.02 | 7.86 | ||
Change | -0.25 | +0.01 | -0.47 | ||
% Change | -2.19% | +0.12% | -5.64% | ||
Volume | 131,060 | 187,413 | 213,927 | ||
20-Day Average Volume | 847,575 | 1,199,036 | 711,527 | ||
Previous Close | 11.44 | 8.01 | 8.33 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 11.33 | 7.58 | 8.20 | ||
20-Day Raw Stochastic | 37.05% | 85.41% | 39.12% | ||
20-Day Relative Strength | 37.07% | 62.66% | 40.87% | ||
Weighted Alpha | -48.36 | -46.08 | -39.21 | ||
Today's Opinion | 100% Sell | 56% Buy | 100% Sell | ||
Previous Opinion | 80% Sell | 56% Buy | 88% Sell | ||
Last Month's Opinion | 88% Sell | 8% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -2.98% since 03/14/25 | +4.13% since 03/14/25 | -7.79% since 03/14/25 | ||
Low | 11.19 on 03/19/25 | 7.70 on 03/17/25 | 7.70 on 03/18/25 | ||
High | 11.74 on 03/17/25 | 8.22 on 03/17/25 | 9.03 on 03/17/25 | ||
1-Month | |||||
%Chg | +1.95% since 02/21/25 | +9.97% since 02/21/25 | -4.80% since 02/21/25 | ||
Low | 10.62 on 03/11/25 | 6.98 on 03/11/25 | 7.22 on 03/04/25 | ||
High | 12.28 on 03/06/25 | 8.22 on 03/17/25 | 9.03 on 03/17/25 | ||
3-Month | |||||
%Chg | -34.03% since 12/20/24 | +43.30% since 12/20/24 | -32.11% since 12/20/24 | ||
Low | 9.77 on 01/15/25 | 5.09 on 12/24/24 | 7.22 on 03/04/25 | ||
High | 17.50 on 12/23/24 | 8.22 on 03/17/25 | 12.98 on 02/05/25 | ||
6-Month | |||||
%Chg | -79.87% since 09/20/24 | +7.19% since 09/20/24 | -42.33% since 09/20/24 | ||
Low | 9.77 on 01/15/25 | 4.62 on 11/20/24 | 7.22 on 03/04/25 | ||
High | 72.37 on 12/09/24 | 8.70 on 10/29/24 | 14.72 on 11/14/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 464,029 | 492,463 | 450,470 | ||
Shares Outstanding, K | 40,562 | 61,481 | 54,078 | ||
Annual Sales | 3,550,000 | 41,240,000 | 8,780,000 | ||
Annual Net Income | -187,350,000 | -400,670,000 | -104,700,000 | ||
Last Quarter Sales | 3,040,000 | 12,820,000 | 4,890,000 | ||
Last Quarter Net Income | -46,030,000 | -95,780,000 | -26,430,000 | ||
60-Month Beta | 1.39 | 0.82 | 0.99 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.14 on 02/26/25 | -1.56 on 02/11/25 | -0.18 on 03/18/25 | ||
Latest Earnings Date | 05/14/25 | 04/24/25 | 05/05/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |